Case report of extranodal natural killer/T-cell lymphoma that induced secondary hemophagocytic syndrome-related histiocytic glomerulopathy

被引:2
作者
Xiao, Fei [1 ]
Hou, Shihui [1 ]
Kui, Kaizhen [1 ]
Wang, Xiaoyue [1 ]
Bai, Lihua [1 ]
Dai, Huanzi [2 ,3 ]
机构
[1] Army Med Univ, Daping Hosp, Dept Nephrol, Chongqing, Peoples R China
[2] Army Med Univ, Daping Hosp, Dept Rheumatol & Clin Immunol, Chongqing, Peoples R China
[3] Army Med Univ, Daping Hosp, Dept Rheumatol & Clin Immunol, 10 Yangtze River Rd, Chongqing 400042, Peoples R China
关键词
Histiocytic glomerulopathy; hemophagocytic syndrome; extranodal natural killer; T-cell lymphoma; proteinuria; podocyte damage; renal biopsy; LYMPHOHISTIOCYTOSIS;
D O I
10.1177/03000605231158952
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hemophagocytic syndrome (HPS) is a proliferative disease of the mononuclear macrophage system involving multiple organs and systems. We report a 50-year-old Asian woman who presented with unexplained fever and proteinuria. Laboratory tests showed cytopenia, considerably elevated serum ferritin and IL-2 receptor concentrations, and evidence of hemophagocytosis in the bone marrow. A renal biopsy showed macrophage infiltration into the glomerulus, resulting in podocyte and endothelial cell damage. We finally diagnosed the patient with extranodal natural killer/T-cell lymphoma, nasal type that induced HPS-related histiocytic glomerulopathy. Proteinuria and inflammation responded to treatment with high-dose pulsed methylprednisolone combined with VP-16 and cyclosporine. To the best of our knowledge, this is the first documented case of HPS-related histiocytic glomerulopathy triggered by a malignant tumor.
引用
收藏
页数:10
相关论文
共 17 条
  • [1] Histiocytic Glomerulopathy Associated With Hemophagocytic Lymphohistiocytosis
    Dokouhaki, Pouneh
    Van der Merwe, Da-elene
    Vats, Karan
    Said, Samar M.
    D'Agati, Vivette D.
    Nasr, Samih H.
    [J]. KIDNEY MEDICINE, 2022, 4 (02)
  • [2] Histiocytic glomerulopathy associated with macrophage activation syndrome
    Eirin, Alfonso
    Irazabal, Maria V.
    Fervenza, Fernando C.
    Sethi, Sanjeev
    [J]. CLINICAL KIDNEY JOURNAL, 2015, 8 (02) : 157 - 160
  • [3] Chronic Active Epstein-Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?
    Fujiwara, Shigeyoshi
    Nakamura, Hiroyuki
    [J]. CANCERS, 2020, 12 (11) : 1 - 15
  • [4] Gagnier JJ, 2013, DTSCH ARZTEBL INT, V110, P603, DOI [10.1136/bcr-2013-201554, 10.3238/arztebl.2013.0603, 10.1186/1752-1947-7-223, 10.7453/gahmj.2013.008]
  • [5] Hiser Wesley, 2020, Proc (Bayl Univ Med Cent), V34, P153, DOI 10.1080/08998280.2020.1805715
  • [6] Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome
    Jia, Jing
    Song, Yuqin
    Lin, Ningjing
    Liu, Weiping
    Ping, Lingyan
    Zheng, Wen
    Wang, Xiaopei
    Xie, Yan
    Tu, Meifeng
    Zhang, Chen
    Ying, Zhitao
    Deng, Lijuan
    Ding, Ning
    Zhu, Jun
    [J]. ANNALS OF HEMATOLOGY, 2016, 95 (12) : 2023 - 2031
  • [7] What nephrologists need to know about hemophagocytic syndrome
    Karras, Alexandre
    [J]. NATURE REVIEWS NEPHROLOGY, 2009, 5 (06) : 329 - 336
  • [8] Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
    La Rosee, Paul
    Horne, AnnaCarin
    Hines, Melissa
    Greenwood, Tatiana von Bahr
    Machowicz, Rafal
    Berliner, Nancy
    Birndt, Sebastian
    Gil-Herrera, Juana
    Girschikofsky, Michael
    Jordan, Michael B.
    Kumar, Ashish
    van Laar, Jan A. M.
    Lachmann, Gunnar
    Nichols, Kim E.
    Ramanan, Athimalaipet, V
    Wang, Yini
    Wang, Zhao
    Janka, Gritta
    Henter, Jan-Inge
    [J]. BLOOD, 2019, 133 (23) : 2465 - 2477
  • [9] Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis
    Liu, Yi-Zhen
    Bi, Lan-Qing
    Chang, Gui-Lin
    Guo, Ye
    Sun, Si
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 997 - 1002
  • [10] Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis
    Marsh, Rebecca A.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 8